Breast cancer in systemic lupus erythematosus

Oncology (Switzerland)

Volumn 85, Issue 2, 2013, Pages 117-121

  Tessier Cloutier, B ^a   Clarke, A E ^a   Ramsey Goldman, R ^b   Wang, Y ^a   Foulkes, W ^c   Gordon, C ^d   Hansen, J E ^e   Yelin, E ^f   Urowitz, M B ^g   Gladman, D ^g   Fortin, P R ^h   Wallace, D J ⁱ   Petri, M ^j   Manzi, S ^k   Ginzler, E M ^l   Labrecque, J ^a   Edworthy, S ^m   Dooley, M A ⁿ   Senecal J L ^o   Peschken, C A ^p   Bae, S C ^q   Isenberg, D ^r   Rahman, A ^r   Ruiz Irastorza, G ^s   Hanly, J G ^t   Jacobsen, S ^u   Nived, O ^v   Witte, T ^w   Criswell, L A ^x   Barr, S G ^m   Dreyer, L ^y   Sturfelt, G ^v   Bernatsky, S ^a   more..

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g TORONTO WESTERN HOSPITAL   (Canada)

^h UNIVERSITÉ LAVAL   (Canada)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k ALLEGHENY GENERAL HOSPITAL   (United States)

^l SUNY DOWNSTATE MEDICAL CENTER   (United States)

^m UNIVERSITY OF CALGARY   (Canada)

ⁿ UNIVERSITY OF NORTH CAROLINA   (United States)

^o CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^p UNIVERSITY OF MANITOBA   (Canada)

^q Hanyang Institute of Bioscience and Biotechnology   (South Korea)

^r UNIVERSITY COLLEGE LONDON   (United Kingdom)

^s HOSPITAL DE CRUCES   (Spain)

^t DALHOUSIE UNIVERSITY   (Canada)

^u International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^v LUND UNIVERSITY HOSPITAL   (Sweden)

^w HANNOVER MEDICAL SCHOOL   (Germany)

^x UNIVERSITY OF CALIFORNIA   (United States)

^y GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

Breast cancer; Epidemiology; Histopathology; Systemic lupus erythematosus

Indexed keywords

ADENOID CYSTIC CARCINOMA; ADULT; AGE; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COLLOID CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; MIXED TUMOR; MULTICENTER STUDY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; BREAST ADENOCARCINOMA; DATA ANALYSIS; DISEASE DURATION; HISTOLOGY; MIDDLE AGED;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS;

EID: 84880396935     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000353138     Document Type: Article

References (17)

1. Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin JF, Petri M, Zoma A, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler E, Yelin E, Bae SC, Wallace DJ, Edworthy S, Jacobsen S, Gordon C, Dooley MA, Peschken CA, Hanly JG, Alarcón GS, Nived O, Ruiz- Irastorza G, Isenberg D, Rahman A, Witte T, Aranow C, Kamen DL, Steinsson K, Askanase A, Barr S, Criswell LA, Sturfelt G, Patel NM, Senécal JL, Zummer M, Pope JE, Ensworth S, El-Gabalawy H, McCarthy T, Dreyer L, Sibley J, St Pierre Y, Clarke AE: Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun 2013; 42: 130-135.
2. Li CI, Uribe DJ, Daling JR: Clinical characteristics of different histologic types of breast cancer. Br J Cancer 2005; 93: 1046-1052.
3. Louwman MW, Vriezen M, Van Beek MW, Tutein Noltlienius-Puylaert MC, Van Der Sangen MJ, Roumen RM, Kiemeney LA, Coebergh JW: Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer 2007; 121: 127- 135.
4. Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (eds): SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988-2001, Patient and Tumor Characteristics. Bethesda, National Cancer Institute, 2007, SEER Program, NIH Pub No 07-6215.
5. Gadalla SM, Amr S, Langenberg P, Baumgarten M, Davidson WF, Schairer C, Engels EA, Pfeiffer RM, Goedert JJ: Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based casecontrol study. Br J Cancer 2009; 100: 817-821.
6. Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, Banham AH: Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 2006; 24: 5373-5380.
7. Chavele KM, Ehrenstein MR: Regulatory Tcells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett 2011; 585: 3603-3610.
8. Hansen JE, Chan G, Liu Y, Hegan DC, Dalal S, Dray E, Kwon Y, Xu Y, Xu X, Peterson- Roth E, Geiger E, Liu Y, Gera J, Sweasy JB, Sung P, Rockwell S, Nishimura RN, Weisbart RH, Glazer PM: Targeting cancer with a lupus autoantibody. Sci Transl Med 2012; 4: 157ra142.
9. Stratton MR: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 1997; 349: 1505-1510.
10. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds): SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, National Cancer Institute. http:// seer.cancer.gov/csr/1975-2009-pops09/ (based on November 2011 SEER data submission, posted to the SEER web site April 2012).
11. Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, Partridge AH: Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 2012; 131: 1061-1066.
12. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin P, Gordon C, Barr S, Edworthy S, Bae SC, Petri M, Sibley J, Isenberg D, Rahman A, Steinsson K, Aranow C, Dooley MA, Alarcon GS, Hanly J, Sturfelt G, Nived O, Pope J, Ensworth S, Rajan R, El-Gabalawy H, McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R: Race/ethnicity and cancer occurrence in systemic lupus erythematosus. Arthritis Care Res 2005; 53: 781-784.
13. Fisher CJ, Egan MK, Smith P, Wicks K, Millis RR, Fentiman IS: Histopathology of breast cancer in relation to age. Br J Cancer 1997; 75: 593-596.
14. Rahim R, Strobl JS: Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. Anticancer Drugs 2009; 20: 736-745.
15. Moran EM: Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks. J Environ Pathol Toxicol Oncol 2002; 21: 193-201.
16. Bernatsky S, Clarke A, Suissa S: Antimalarial drugs and malignancy: no evidence of a protective effect in rheumatoid arthritis. Ann Rheum Dis 2008; 67: 277-278.
17. Bernatsky S, Joseph L, Boivin JF, Gordon C, Urowitz M, Gladman D, Fortin PR, Ginzler E, Bae SC, Barr S, Edworthy S, Isenberg D, Rahman A, Petri M, Alarcón GS, Aranow C, Dooley MA, Rajan R, Sénécal JL, Zummer M, Manzi S, Ramsey-Goldman R, Clarke AE: The relationship between cancer and medication exposures in systemic lupus erythematosus: a casecohort study. Ann Rheum Dis 2008; 67: 74-79.